AnalystsChris RaymondChris Raymond's Stock Forecasts
AnalystsChris Raymond
Sectors:
Industries:
Analyst Ranking
Top 29%
#1499 out of 5256 analysts
Average Return
+51%
Win Rate
67%6 out of 9
Risk vs Reward
Poor
Good
Chris Raymond's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Cogent Biosciences IncCOGT | +182.87% | $13.08 | $37.00 | 2025-09-02 - 2026-04-20 | Strong Buy |
Tyra Biosciences IncTYRA | +178.98% | $12.32 | $34.37 | 2025-09-02 - 2026-04-20 | Strong Buy |
Sionna Therapeutics IncSION | +73.69% | $24.55 | $42.64 | 2025-09-02 - 2026-04-20 | Strong Buy |
Monopar TherapeuticsMNPR | +51.06% | $36.21 | $54.70 | 2025-09-02 - 2026-04-20 | Strong Buy |
Kalaris Therapeutics IncKLRS | +44.42% | $4.57 | $6.60 | 2025-09-02 - 2026-04-20 | Strong Buy |
Chris Raymond Analyst Color
Get additional color on Chris Raymond's coverage of popular stocks
Chris Raymond's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Monopar TherapeuticsMNPR | 3 | Buy | $123.00 | +124.86% | Downgrades | 5 months ago |
Sionna Therapeutics IncSION | 1 | Strong Buy | $45.00 | +5.53% | Initiates Coverage On | 8 months ago |
Tyra Biosciences IncTYRA | 1 | Strong Buy | $35.00 | +1.83% | Initiates Coverage On | 8 months ago |
Nuvalent IncNUVL | 1 | Buy | $105.00 | -2.99% | Initiates Coverage On | 8 months ago |
Kalaris Therapeutics IncKLRS | 1 | Strong Buy | $23.00 | +248.48% | Initiates Coverage On | 8 months ago |
Cogent Biosciences IncCOGT | 1 | Strong Buy | $30.00 | -18.92% | Initiates Coverage On | 8 months ago |
Biohaven LtdBHVN | 1 | Strong Buy | $75.00 | +593.16% | Initiates Coverage On | 8 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.